Colombia exceeded 10,000 deaths from coronavirus
Photo by: AS-Colombia
According to the report of the Health portfolio, in the last 24 hours there were 295 deaths due to the virus and 154,387 recovered, while active cases reached 130,403.
This Friday, the areas of the country that registered the most new cases of coronavirus are distributed as follows:
• Bogotá: 3,717
• Antioquia: 2,073
• Valley: 668
• Atlantic: 301
• Cundinamarca: 274
• Santander: 266
• Barranquilla: 229
• Norte de Santander: 203
• Cartagena: 200
• Nariño: 200
• Bolívar: 133
According to the authorities, Colombia has 855 conglomerates that are monitored for the contagion of covid-19, distributed as follows: Amazonas, Antioquia (Ituango), Arauca, Atlántico, Barranquilla, Bogotá, Boyacá, Bolívar, Buenaventura , Caldas, Caquetá, Cartagena, Cauca, Cesar, Chocó, Córdoba, Cundinamarca, Huila, La Guajira, Magdalena, Meta, Nariño, Norte de Santander, Quindío, Risaralda, San Andrés, Santa Marta, Santander, Sucre, Tolima, Valle, Vaupés, Vichada, Guaviare and Guainía.
In history, until this Friday, the places with the highest number of confirmed infections are: Bogotá, which reached 101,955 cases of covid-19; Atlántico with a total of 52,313 cases; Antioquia with 32,759 and Valle del Cauca with 24,660 cases. In recent days, the National Institute for Food and Drug Surveillance (Invima) approved the use of the drug Interferon Beta to treat symptoms associated with covid-19, but only in clinical trials approved by the same entity.
According to Invima, to date, there is no scientific evidence that proves the efficacy and safety of the drug Interferon Beta in the prevention or treatment of patients with symptoms associated with covid-19.
The Invima clarified that it can only be used in the nine institutions that have approval, to date, within the framework of the clinical trial: in Bogotá, in the Colombia Clinic, the Santa María del Lago Children's Clinic, the Reina Sofía Clinic, the Cardioinfantil Foundation and Santa Fe de Bogotá Foundation; in Cali it can be used at the Sebastián de Belalcázar Clinic, Imbanaco Medical Center and the Valle del Lili Foundation. While it may be supplied at the Iberoamerican Clinic in Barranquilla.
As indicated in the Colombian consensus on care, diagnosis and management of Sars-CoV-2 infection, led by the Colombian Association of Infectious Diseases (Acin) in conjunction with the Institute for Health Technology Assessment (IETS), although there are results of preclinical studies showing that Interferon type I and II IFN Beta have better efficacy in reducing MERS CoV replication, in cell cultures, to date there are no robust results and their safety is low.
